CAMBRIDGE, Mass.--(BUSINESS WIRE)--Molecular Insight Pharmaceuticals, Inc. (NASDAQ: MIPI) announced today that David S. Barlow, Chairman and Chief Executive Officer of Molecular Insight Pharmaceuticals, will participate on a panel called “Novel Cancer Targets” at the 2007 RBC Capital Markets Healthcare Conference on Wednesday, December 12, 2007. During the panel presentation and discussion, Mr. Barlow will provide an overview of the company and its pipeline of molecular radiotherapeutic and molecular imaging pharmaceutical candidates. The panel presentation will take place at 2:30 p.m. Eastern Time at The Westin New York at Times Square in New York, New York.